Follow

Submissions from 2021

Consequences of the COVID-19 Pandemic on Cancer Clinical Trials., S. Flores, N. Kurian, A. Yohannan, C. Persaud, and M. W. Saif

Link

Primary thromboprophylaxis in a patient with type 3 von Willebrand disease and severe COVID-19 infection, A. Vagrecha, J. Stanco, S. Majeed, P. Kouides, and S. S. Acharya

Submissions from 2020

Link

The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients, B. Alman, S. Attia, C. Baumgarten, C. Benson, J. Blay, S. Bonvalot, J. Breuing, K. Cardona, R. Maki, N. Zafiropoulos, and +47 additional authors

PDF

Life Threatening haemoptysis in primary lung cancer-signet ring cell carcinoma, S. Anwar, S. Acharya, D. Elsayegh, A. Sokoloff, and M. Rehan

Link

Evaluation of the efficacy and safety of arsenic trioxide dosing in obese patients with acute promyelocytic leukemia, B. Barsoum, A. Henneman, S. Ahmad, and C. Ghiuzeli

Link

Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/KMT2A, M. Bill, K. Mrózek, J. Kohlschmidt, A. K. Eisfeld, C. J. Walker, D. Nicolet, D. Papaioannou, J. S. Blachly, J. E. Kolitz, C. D. Bloomfield, and +6 additional authors

PDF

Mutations associated with a 17-gene leukemia stem cell score and the score’s prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemia, M. Bill, D. Nicolet, J. Kohlschmidt, C. J. Walker, K. Mrózek, A. K. Eisfeld, D. Papaioannou, X. Rong-Mullins, J. E. Kolitz, C. D. Bloomfield, and +8 additional authors

PDF

COVID-19 Clinical Research., J. Chi, D. Chitty, M. Lee, N. Hakim, S. Lakhani, L. Rajdev, X. Zhu, and M. W. Saif

PDF

Evaluating of HPV-DNA ISH as an adjunct to p16 testing in oropharyngeal cancer, J. Chi, I. R. Preeshagul, S. Sheikh-Fayyaz, S. Teckie, N. Kohn, Y. Ziemba, A. Laser, D. Frank, M. Ghaly, D. Kamdar, D. Kraus, D. Paul, and N. Seetharamu

Dose-escalation trial of the ALK, MET & ROS1 inhibitor, crizotinib, in patients with advanced cancer, J. W. Clark, D. R. Camidge, E. L. Kwak, R. G. Maki, G. I. Shapiro, I. Chen, W. Tan, S. Randolph, J. G. Christensen, R. Salgia, and +3 additional authors

PDF

Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas, A. R. Dancsok, D. Gao, A. F. Lee, S. E. Steigen, J. Blay, D. M. Thomas, R. G. Maki, T. O. Nielsen, and E. G. Demicco

Link

Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network, G. D. Demetri, C. R. Antonescu, B. Bjerkehagen, J. V. Bovee, K. Boye, M. Chacon, A. P. Dei Tos, J. Desai, R. Maki, J. Blay, and +38 additional authors

PDF

Lessons Learnt from COVID-19: How Can We Prepare for Another Pandemic?, M. I. Ehrlich and M. W. Saif

Link

Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 >years, A. K. Eisfeld, J. Kohlschmidt, A. Mims, D. Nicolet, C. J. Walker, J. S. Blachly, A. J. Carroll, D. Papaioannou, J. E. Kolitz, C. D. Bloomfield, and +5 additional authors

Link

Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma., K. R. Gundle, G. B. Deutsch, H. J. Goodman, S. M. Pollack, M. J. Thompson, J. L. Davis, M. Lee, D. C. Ramirez, W. Kerwin, R. G. Maki, and +8 additional authors

Identifying patterns of failure and secondary primary malignancies in HPV-related oropharyngeal squamous cell carcinomas, R. Holstead, R. Rasul, A. Golden, D. Kamdar, M. Ghaly, S. Teckie, D. Frank, J. Fantasia, and N. Seetharamu

Link

Consolidation outcomes in CPX-351 versus cytarabine/daunorubicin-treated older patients with high-risk/secondary acute myeloid leukemia, J. E. Kolitz, S. A. Strickland, J. E. Cortes, D. Hogge, J. E. Lancet, S. L. Goldberg, K. F. Villa, R. J. Ryan, M. Chiarella, R. K. Stuart, and +2 additional authors

Link

Bevacizumab-induced dysphonia: A case report with brief review of literature, S. Y. Lam, C. S. Lee, S. Sharma, and K. Cheng

PDF

Pretreatment nutritional status and response to checkpoint inhibitors in lung cancer., C. Lee, C. E. Devoe, X. Zhu, J. S. Fishbein, and N. Seetharamu

PDF

A comprehensive review of contemporary literature for epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer and their toxicity, C. S. Lee, S. Sharma, E. Miao, C. Mensah, K. Sullivan, and N. Seetharamu

Link

Lorlatinib induced proteinuria: A case report, C. Lee, R. Wanchoo, and N. Seetharamu

Link

Follicular dendritic cell sarcoma and its response to immune checkpoint inhibitors nivolumab and ipilimumab, M. Y. Lee, C. Bernabe-Ramirez, D. C. Ramirez, and R. G. Maki

PDF

A Case of Vancomycin-Induced Immune Thrombocytopenia., K. N. MacDougall, S. Parylo, and A. Sokoloff

PDF

Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801, G. Marcucci, S. Geyer, K. Laumann, W. Zhao, D. Bucci, G. L. Uy, W. Blum, A. K. Eisfeld, J. E. Kolitz, R. A. Larson, and +7 additional authors

Link

Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology, M. J. Markham, K. Wachter, N. Agarwal, M. M. Bertagnolli, S. M. Chang, W. Dale, C. S. Diefenbach, C. Rodriguez-Galindo, R. G. Maki, S. N. Westin, and +16 additional authors

PDF

Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID-19 Pandemic, J. Martin-Broto, N. Hindi, S. Aguiar, R. Badilla-Gonzalez, V. Castro-Oliden, M. Chacon, R. Correa-Generoso, E. de alava, R. Maki, J. Blay, and +25 additional authors

Link

Comparison of clinical and molecular characteristics of patients with acute myeloid leukemia and either TP73 or TP53 mutations, A. S. Mims, J. Kohlschmidt, A. K. Eisfeld, K. Mrόzek, J. S. Blachly, S. Orwick, D. Papaioannou, D. Nicolet, J. E. Kolitz, C. D. Bloomfield, and +4 additional authors

PDF

Multiplex accurate sensitive quantitation (MASQ) with application to minimal residual disease in acute myeloid leukemia, A. B. Moffitt, M. S. Spector, P. Andrews, J. Kendall, J. Alexander, A. Stepansky, J. Kolitz, N. Chiorazzi, S. L. Allen, Z. Wang, and +4 additional authors

Link

Single-cell sequencing in genitourinary malignancies, N. Murphy, P. Shah, A. Shih, H. Khalili PSYD, A. Liew, X. Zhu, and A. Lee

PDF

Optimizing Tissue Use: A Step-wise Approach to Diagnosing Squamous Cell Lung Carcinoma on Small Biopsies, C. Olazagasti, I. Preeshagul, M. Aziz, and N. Seetharamu

Link

Caring for Patients With Cancer in the Face of Self-Vulnerability During the COVID-19 Pandemic-Reply., C. Olazagasti and N. Seetharamu

Link

Facing a Pandemic while Pregnant, C. Olazagasti and N. Seetharamu

PDF

Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia, J. M. Pagel, M. Othus, G. Garcia-Manero, M. Fang, J. P. Radich, D. A. Rizzieri, G. Marcucci, S. A. Strickland, R. L. Bayer, F. R. Appelbaum, and +10 additional authors

PDF

Clinical and functional significance of circular RNAs in cytogenetically normal AML, D. Papaioannou, S. Volinia, D. Nicolet, M. Swierniak, A. Petri, K. Mrozek, M. Bill, F. Pepe, J. E. Kolitz, R. Garzon, and +10 additional authors

PDF

COVID-19 and Cancer Patients., R Patel, J Park, A Shah, and MW Saif

Link

The impact of precision medicine on real-world clinical care: A single institution retrospective study, R. Patel, R. Quinn, and X. Zhu

PDF

Management of Pancreatic Cancer During COVID-19 Pandemic: To Treat or Not to Treat?, R. Patel and M. W. Saif

Link

Association Between Pretreatment Sleep Disturbance and Radiation Therapy-Induced Pain in 573 Women With Breast Cancer, A. R. Peoples, W. R. Pigeon, D. Li, S. N. Garland, M. L. Perlis, J. E. Inglis, V. Vinciguerra, T. Anderson, L. S. Evans, J. R. Wolf, and +3 additional authors

Link

Ibrutinib-associated Arthralgias/Myalgias in Patients With Chronic Lymphocytic Leukemia: Incidence and Impact on Clinical Outcomes, J. M. Rhodes, V. A. LoRe, A. R. Mato, E. A. Chong, J. C. Barrientos, J. N. Gerson, S. K. Barta, D. J. Landsburg, S. D. Nasta, S. J. Schuster, and +2 additional authors

PDF

A Randomized,Double-Blind,Placebo-Controlled, PhaseIIStudy of Regorafenib Versus Placebo in Advanced/Metastatic,Treatment-RefractoryLiposarcoma: Results from theSARC024Study, R. F. Riedel, K. Ballman, Y. Lu, S. Attia, E. T. Loggers, K. N. Ganjoo, M. B. Livingston, W. Chow, J. Wright, R. G. Maki, and +10 additional authors

PDF

A framework for advancing our understanding of cancer-associated fibroblasts, E. Sahai, I. Astsaturov, E. Cukierman, D. G. DeNardo, M. Egeblad, R. M. Evans, D. Fearon, R. G. Maki, D. C. Ramirez, Z. Werb, and +10 additional authors

Link

Carfilzomib Induced Tumor Lysis Syndrome and Other Adverse Events, E. B. Sandy, C. Weerasinghe, and T. Terjanian

PDF

Ibrutinib restores immune cell numbers and function in first-line and relapsed/refractory chronic lymphocytic leukemia, I. G. Solman, L. K. Blum, H. Y. Hoh, T. J. Kipps, J. A. Burger, J. C. Barrientos, S. O'Brien, S. P. Mulligan, N. E. Kay, A. Mongan, and +4 additional authors

Link

Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration., D. M. Stephens, K. Boucher, E. Kander, S. A. Parikh, E. M. Parry, M. Shadman, J. M. Pagel, J. Cooperrider, J. Rhodes, J. C. Byrd, and +11 additional authors

Updates in Neoadjuvant Therapy for Triple Negative Breast Cancer, A. M. Tufano, E. Teplinsky, and C. A. Landry

Submissions from 2019

PDF

Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma, N. E. Berlow, R. Rikhi, M. Geltzeiler, J. Abraham, M. N. Svalina, L. E. Davis, E. Wise, M. Mancini, R. G. Maki, C. Keller, and +19 additional authors

Link

Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21, B. Bhatnagar, A. K. Eisfeld, J. Kohlschmidt, K. Mrózek, D. Nicolet, D. Papaioannou, C. J. Walker, S. Orwick, J. E. Kolitz, C. D. Bloomfield, and +5 additional authors

PDF

Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study, J. Blay, P. Schoffski, S. Bauer, A. Krarup-Hansen, C. Benson, D. R. D'Adamo, Y. Jia, and R. G. Maki

Link

Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas, A. R. Dancsok, N. Setsu, D. Gao, J. Y. Blay, D. Thomas, R. G. Maki, T. O. Nielsen, and E. G. Demicco

PDF

Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715)., D. Dao, T. Zemla, A. Jatoi, R. A. Freedman, A. Hurria, H. Muss, H. J. Cohen, M. Citron, D. Budman, J. G. Le-Rademacher, and +6 additional authors

Link

Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma, L. E. Davis, V. Bolejack, C. W. Ryan, K. N. Ganjoo, E. T. Loggers, S. Chawla, M. Agulnik, M. B. Livingston, D. Reed, R. G. Maki, and +7 additional authors

Link

A retrospective analysis of tumor lysis syndrome management in a quaternary care hospital., S. Eng, C. Lee, S. Ahn, and A. Sharma

Link

Mechanism for IL-15-Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response Proteins, R. Gupta, W. Li, X. J. Yan, J. Barrientos, J. E. Kolitz, S. L. Allen, K. Rai, N. Chiorazzi, and P. K. Mongini

PDF

A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas, R. L. Jones, S. P. Chawla, S. Attia, P. Schoffski, H. Gelderblom, B. Chmielowski, A. Le Cesne, B. A. Van Tine, J. C. Trent, R. G. Maki, and +7 additional authors

Link

Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin, R. L. Jones, R. G. Maki, S. R. Patel, G. Wang, T. A. McGowan, W. S. Shalaby, R. E. Knoblauch, M. von Mehren, and G. D. Demetri

PDF

Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours, R. L. Jones, M. J. Ratain, P. J. O'Dwyer, L. L. Siu, J. Jassem, J. Medioni, M. DeJonge, C. Rudin, R. Maki, G. Schwartz, and +20 additional authors

PDF

An Atypical Presentation of Lichen Planus-Like Reaction from Pembrolizumab., M. Lee and N. Seetharamu

Link

Novel HMGA2-YAP1 fusion gene in aggressive angiomyxoma, M. Y. Lee, B. Da Silva, D. C. Ramirez, and R. G. Maki

PDF

An IRAK1-PIN1 signalling axis drives intrinsic tumour resistance to radiation therapy, P. H. Liu, R. B. Shah, Y. Li, A. Arora, P. M. Ung, R. Raman, A. Gorbatenko, S. Kozono, R. G. Maki, S. Sidi, and +13 additional authors

PDF

Radiation recall pneumonitis in the setting of immunotherapy and radiation: A focused review, K. McGovern, M. Ghaly, M. Esposito, K. Barnaby, and N. Seetharamu

Link

Impact of Tyrosine Kinase Inhibitor Starting Dose on Outcomes in Patients With Non-Small Cell Lung Cancer, E. Miao, N. Seetharamu, K. Sullivan, S. Eng, and C. S. Lee

PDF

Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinically, K. Mrózek, A. K. Eisfeld, J. Kohlschmidt, A. J. Carroll, C. J. Walker, D. Nicolet, J. S. Blachly, M. Bill, J. E. Kolitz, C. D. Bloomfield, and +7 additional authors

Link

An unusual case of Kaposi sarcoma masquerading as cystitis in a kidney transplant recipient, V. Nair, F. Sheikh, D. Hirschwerk, A. Fahmy, M. Bhaskaran, E. Grodstein, A. Winnick, R. Maki, L. Teperman, and E. Molmenti

Link

Prognostic and biologic relevance of clinically applicable long noncoding RNA profiling in older patients with cytogenetically normal acute myeloid leukemia, D. Papaioannou, D. Nicolet, H. G. Ozer, K. Mrozek, S. Volinia, P. Fadda, A. J. Carroll, J. Kohlschmidt, J. E. Kolitz, C. D. Bloomfield, and +4 additional authors

PDF

Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma, S. Patel, M. von Mehren, D. R. Reed, P. Kaiser, J. Charlson, C. W. Ryan, D. Rushing, M. Livingston, R. G. Maki, G. D. Demetri, and +10 additional authors

PDF

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors, M. A. Pulsipher, B. R. Logan, D. M. Kiefer, P. Chitphakdithai, M. L. Riches, D. Rizzo, P. Anderlini, R. Bayer, I. Sahdev, B. E. Shaw, and +51 additional authors

PDF

Excellent Response to Nivolumab and Ipilimumab in Metastatic Gastroesophageal Junction Squamous Carcinoma., N. Sadagopan and C. Devoe

Link

Acute kidney injury in hematopoietic stem cell transplantation, R. Wanchoo, B. R. Stotter, R. L. Bayer, and K. D. Jhaveri

Submissions from 2018

Link

Characterizing the kinetics of lymphocytosis in patients with chronic lymphocytic leukemia treated with single-agent ibrutinib, J. C. Barrientos, J. A. Burger, J. C. Byrd, P. Hillmen, C. Zhou, J. Ninomoto, D. F. James, and T. J. Kipps

PDF

Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL, J. R. Brown, P. Hillmen, S. O'Brien, J. C. Barrientos, N. M. Reddy, S. E. Coutre, C. S. Tam, S. P. Mulligan, U. Jaeger, J. C. Byrd, and +20 additional authors

Link

A Method to Summarize Toxicity in Cancer Randomized Clinical Trials., M. Carbini, M. Suárez-Fariñas, and R. G. Maki

Link

A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors, D. R. D'Adamo, M. A. Dickson, M. L. Keohan, R. D. Carvajal, M. L. Hensley, C. M. Hirst, M. O. Ezeoke, L. Ahn, R. G. Maki, W. D. Tap, and +4 additional authors

Link

TERT promoter mutations in solitary fibrous tumour, E. G. Demicco, K. Wani, D. Ingram, M. Wagner, R. G. Maki, A. Rizzo, A. Meeker, A. J. Lazar, and W. L. Wang

PDF

Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: An analysis of Alliance studies, A. K. Eisfeld, J. Kohlschmidt, K. Mrózek, J. S. Blachly, C. J. Walker, D. Nicolet, S. Orwick, S. E. Maharry, J. E. Kolitz, C. D. Bloomfield, and +6 additional authors

PDF

NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome, A. K. Eisfeld, J. Kohlschmidt, K. Mrózek, A. Mims, C. J. Walker, J. S. Blachly, D. Nicolet, S. Orwick, J. E. Kolitz, C. D. Bloomfield, and +7 additional authors

Link

Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal Expansion, R. Gupta, X. J. Yan, J. Barrientos, J. E. Kolitz, S. L. Allen, K. Rai, N. Chiorazzi, and P. K. Mongini

Link

Massive liver metastasis from colon adenocarcinoma causing cardiac tamponade, A. N. Halthore, A. Levy, T. Philip, and S. Teckie

Link

Clinical cancer advances 2018: Annual report on progress against cancer from the American Society of Clinical Oncology, J. Heymach, L. Krilov, A. Alberg, N. Baxter, S. M. Chang, R. Corcoran, W. Dale, A. DeMichele, R. G. Maki, H. Burstein, and +12 additional authors

Link

Rasburicase-induced methemoglobinemia: The eyes do not see what the mind does not know, U. Ibrahim, A. Saqib, F. Mohammad, J. P. Atallah, and M. Odaimi

Link

Efficacy and tolerability of trabectedin in elderly patients with sarcoma: Subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma, R. L. Jones, G. D. Demetri, S. M. Schuetze, M. Milhem, A. Elias, B. A. Van Tine, J. Hamm, S. McCarthy, R. G. Maki, M. Von Mehren, and +5 additional authors

Link

Pathologic Angiogenesis of Malignant Vascular Sarcomas: Implications for Treatment, J. A. Khan, R. G. Maki, and V. Ravi

PDF

Cpx-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia, J. E. Lancet, G. L. Uy, J. E. Cortes, L. F. Newell, T. L. Lin, E. K. Ritchie, R. K. Stuart, S. A. Strickland, J. E. Kolitz, B. C. Medeiros, and +11 additional authors

Link

Paraneoplastic Syndrome Secondary to Treatment Emergent Neuroendocrine Tumor in Metastatic Castration-resistant Prostate Cancer: A Unique Case, N. Murphy, J. Shen, A. Shih, A. Liew, H. Khalili, O. Yaskiv, K. Katona, A. Lee, and X. H. Zhu

PDF

Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia, A. Ngankeu, P. Ranganathan, V. Havelange, D. Nicolet, S. Volinia, B. L. Powell, J. E. Kolitz, G. L. Uy, R. M. Stone, R. Garzon, and +4 additional authors

Link

Carcinosarcomas and Related Cancers: Tumors Caught in the Act of Epithelial-Mesenchymal Transition, A. Pang, M. Carbini, A. L. Moreira, and R. G. Maki

PDF

Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics, K. Runcie, D. R. Budman, V. John, and N. Seetharamu

PDF

Merkel cell carcinoma masquerading as cellulitis: A case report and review of the literature, F. Safa, M. Pant, C. Weerasinghe, R. Felix, and T. Terjanian

PDF

Chylothorax in Patients with Chronic Lymphocytic Leukemia: A Case Series., D. Sammartino, S. Khanijo, S. Koenig, J. F. Katsetos, A. Tufano, K. R. Rai, and J. C. Barrientos

PDF

Hybrid capture–based genomic profiling of circulating tumor DNA from patients with advanced cancers of the gastrointestinal tract or anus, A. B. Schrock, D. Pavlick, S. J. Klempner, J. H. Chung, B. Forcier, A. Welsh, L. Young, B. Leyland-Jones, C. Devoe, V. A. Miller, and +9 additional authors

Link

Sarcoma: The Merging of Science and Clinical Care, G. K. Schwartz and R. G. Maki

PDF

Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma, S. Stacchiotti, O. Mir, A. Le Cesne, B. Vincenzi, A. Fedenko, R. G. Maki, N. Somaiah, S. Patel, M. Brahmi, A. Kawai, and +13 additional authors

Link

Extraocular Muscle Metastasis from Esophageal Carcinoma: an Atypical and Rare Presentation, N. Thumallapally, S. El-Bitar, F. Mohammad, and J. P. Atallah

PDF

Synchronous Presence of EGFR, ALK Driver Mutations Along With PD L1 Overexpression in a Resected Early Stage Non-Small Cell Lung Cancer: A Case Report and Review of Literature., N. Thumallapally, S. Parylo, A. Vennepureddy, U. Ibrahim, and A. Sokoloff

Link

Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer, H. Tiriac, P. Belleau, D. D. Engle, D. Plenker, A. Deschenes, D. V. Sejpal, J. D. Sullivan, J. M. Crawford, C. Devoe, D. A. Tuveson, and +60 additional authors

PDF

Genome-wide association study identifies an acute myeloid leukemia susceptibility locus near BICRA, C. J. Walker, C. C. Oakes, L. K. Genutis, B. Giacopelli, S. Liyanarachchi, D. Nicolet, A. K. Eisfeld, M. Scholz, J. E. Kolitz, C. D. Bloomfield, and +12 additional authors

PDF

Renal involvement in chronic lymphocytic leukemia., R. Wanchoo, C. Bernabe Ramirez, J. Barrientos, and K. D. Jhaveri

PDF

Oral curcumin for radiation dermatitis: a URCC NCORP study of 686 breast cancer patients, J. R. Wolf, C. E. Heckler, J. J. Guido, A. R. Peoples, J. S. Gewandter, M. Ling, V. P. Vinciguerra, T. Anderson, L. Evans, G. R. Morrow, and +2 additional authors

Submissions from 2016

Link

A case of acute kidney injury from crystal nephropathy secondary to pomalidomide and levofloxacin use, P. Baird, S. Leung, H. Hoang, O. Babalola, C. E. Devoe, R. Wanchoo, and K. D. Jhaveri

PDF

Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia, J. C. Byrd, B. Harrington, S. O'Brien, J. A. Jones, A. Schuh, S. Devereux, J. Chaves, W. G. Wierda, J. C. Barrientos, R. R. Furman, and +20 additional authors

PDF

Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trials, J. J. Castillo, F. Mulkey, S. Geyer, J. E. Kolitz, W. Blum, B. L. Powell, S. L. George, R. A. Larson, and R. M. Stone